ZEOX — Zeo ScientifiX, Inc.
—
OTC ·
Health Care ·
Biotechnology ·
CIK 1557376 ·
Last close
$1.36
Market Cap
$10.66M
52W High
$2.99
52W Low
$0.97
ADV30
1,780
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Apr 2026 | 2,581,000 | 2,055,000 | -512,000 | -145,000 | 3,886,000 | 1,846,000 | 3,174,000 |
| Jan 2026 | 1,446,000 | 1,165,000 | -878,000 | -852,000 | 2,571,000 | 1,030,000 | 2,954,000 |
| Oct 2025 | 1,654,000 | 1,398,000 | -668,000 | -815,000 | 1,527,000 | 221,000 | 2,950,000 |
| Jul 2025 | 1,306,000 | 1,078,000 | -2,071,000 | -2,072,000 | 1,652,000 | 314,000 | 3,966,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-1,249,000
Investing CF
$275,000
Financing CF
$2,278,000
CapEx
$-78,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.68
As of
2026-09-20
Balance + Analyst (yfinance extras)
Retained Earnings
$-68,731,000
Inventory
$686,000
Receivables
$276,000
ST Investments
—
EBIT TTM
$-3,808,000
Pretax Income TTM
$-3,884,000
Interest Exp TTM
$76,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$6,987,000
EBITDA
$-4,052,000
Free Cash Flow
$60,500
Enterprise Value
$7,510,057
Total Cash
$1,846,000
Total Debt
$343,000
Shares Out
7,837,441
Trailing EPS
$-0.58
Book Value
$0.09
ROE
—
ROA
-97.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Oct 2025 | 5,199,000 | -5,386,000 | -5,521,000 | 1,527,000 | 2,950,000 | -1,423,000 | -718,000 |
| Oct 2024 | 4,620,000 | -5,319,000 | -4,705,000 | 1,643,000 | 3,296,000 | -1,653,000 | -1,450,000 |
| Oct 2023 | 4,558,000 | -6,768,000 | -6,987,000 | 2,782,000 | 4,023,000 | -1,241,000 | -2,197,000 |
| Oct 2022 | 6,491,008 | -8,842,960 | -8,896,557 | 6,200,688 | 4,312,084 | 1,888,604 | -3,165,840 |
| Oct 2021 | — | — | — | — | — | — | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BCLI | BRAINSTORM CELL THERAPEUTICS INC. | $10.70M | $0.97 | — |
| SNTI | Senti Biosciences Holdings, Inc. | $10.25M | $0.33 | — |
| INAB | IN8BIO, INC. | $11.83M | $1.20 | — |
| INTS | INTENSITY THERAPEUTICS, INC. | $12.41M | $3.80 | — |
| PLUR | Pluri Inc. | $12.47M | $1.01 | — |
News headlines (Yahoo Finance, 1h cache)
ZEO ScientifiX Announces Multidisciplinary Expert Faculty Lineup for the ZEO Xperience
2026-09-01 11:00 · Yahoo
ZEO ScientifiX Strengthens South Florida's Growing Biotechnology Ecosystem Through Regenerative Medicine Innovation
2026-07-21 11:00 · Yahoo
ZEO ScientifiX to Host Live Educational Webinar for Healthcare Professionals Exploring the Southeast Regenerative Medicine Revolution
2026-07-01 11:00 · Yahoo
ZEO ScientifiX Launches Physician-Led Patient Masterclass Program Following Grassroots Demand in the Southeast
2026-05-27 11:00 · Yahoo
ZEO ScientifiX (OTCQB: ZEOX) Selected as Qualified Team Advancing into the XPRIZE Healthspan Semi-Finals Stage
2026-04-07 17:56 · Yahoo
ZEO ScientifiX Surpasses 500 Physicians Trained in Regenerative Medicine Compliance; Monthly Masterclasses Average 70+ Clinicians
2026-04-21 11:00 · Yahoo
Regen Therapy Partners with Stealth Health to Bring Specialized Telemedicine Services and Longevity Programs to 3,000 Clinics - Powered by an Exclusive Scientific and Biologics Strategic Collaboration
2026-04-09 11:00 · Yahoo
ZEO ScientifiX Plans Expansion into Georgia and Tennessee as New Regenerative Medicine Laws Take Effect
2026-09-15 11:00 · Yahoo
ZEO ScientifiX Launches First-of-Its-Kind ZEO Xperience, a Three-Day Immersive Regenerative Medicine Experience for Healthcare Professionals
2026-08-04 11:00 · Yahoo
ZEO ScientifiX Reports Strong Revenue Growth for Three Months and Six Months Ended April 30, 2026
2026-07-08 11:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.